Fouad Namouni Blueprint Medicines Corp (BPMC) insider trading activity

Fouad Namouni is PRESIDENT, R & D of Blueprint Medicines Corp. Currently has a direct ownership of 75,781 shares of BPMC, which is worth approximately $6.72 Million. The most recent transaction as insider was on Mar 05, 2025, when has been sold 6,489 shares (Common Stock) at a price of $88.8 per share, resulting in proceeds of $576,223. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 75.8K

9.72% 3M change

4.23% 12M change

Total Value Held $6.72 Million

Fouad Namouni Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 05 2025	SELL Open market or private sale	$576,223 $88.8 p/Share	6,489 Reduced 7.89%	75,781 Common Stock
Mar 01 2025	BUY Grant, award, or other acquisition	-	13,200 Added 13.83%	82,270 Common Stock
Oct 03 2024	SELL Open market or private sale	$324,499 $89.32 p/Share	3,633 Reduced 5.0%	69,070 Common Stock
Mar 07 2024	SELL Open market or private sale	$396,950 $90.69 p/Share	4,377 Reduced 5.68%	72,703 Common Stock
Mar 01 2024	BUY Grant, award, or other acquisition	-	15,000 Added 16.29%	77,080 Common Stock
Oct 04 2023	SELL Open market or private sale	$181,138 $48.06 p/Share	3,769 Reduced 5.72%	62,080 Common Stock
Mar 06 2023	SELL Open market or private sale	$87,737 $45.04 p/Share	1,948 Reduced 2.87%	65,849 Common Stock
Mar 01 2023	BUY Grant, award, or other acquisition	-	15,000 Added 18.12%	67,797 Common Stock
Oct 04 2022	SELL Open market or private sale	$234,002 $67.3 p/Share	3,477 Reduced 6.18%	52,797 Common Stock
Mar 07 2022	SELL Open market or private sale	$58,831 $56.19 p/Share	1,047 Reduced 1.83%	56,274 Common Stock
Mar 01 2022	BUY Grant, award, or other acquisition	-	15,000 Added 20.74%	57,321 Common Stock
Oct 05 2021	SELL Open market or private sale	$318,201 $98.18 p/Share	3,241 Reduced 7.11%	42,321 Common Stock
Mar 01 2021	BUY Grant, award, or other acquisition	-	13,062 Added 22.28%	45,562 Common Stock
Oct 01 2020	BUY Grant, award, or other acquisition	-	32,500 Added 50.0%	32,500 Common Stock

Also insider at

APRE

Aprea Therapeutics, Inc. Healthcare

Director

VOR

Vor Biopharma Inc. Healthcare

Fouad Namouni

PRESIDENT, R & D

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BPMC shares.

Notify only if

Value

Insider Trading

Get notified when an Blueprint Medicines Corp insider buys or sells BPMC shares.

Notify only if

Operation

Value

Type

News

Receive news related to Blueprint Medicines Corp

Track Activities on BPMC

Account